Recently, the list of key core technology research projects in Suzhou for the year 2025 was announced, and Jiangsu Baisaifei Biotechnology Co., Ltd.'s "Research and Development of Biomimetic Anticoagulant Coating Technology for Blood Contact Devices" project was success…
TCT Late Breaking Clinical Session is about to be released: Chinese original world's smallest VAD "NyokAssist®" clinical achievement, impacting the new global standard for high-risk PCI treatment
On September 14, 2025, at the China International Fair for Trade in Services held in Shougang Park, Beijing, Park Heng Bomai and the Future Biotechnology Research Institute of China Science and Technology Corporation officially signed a strategic cooperation agreement.
In the golden September, the academic hall shines brightly.
Recently, The Galien Foundation announced the nominees for the 2025 Prix Galien USA award.
On the clinical front line of cardiology, a thorny dilemma has always plagued doctors and patients: when faced with high-risk PCI surgery……
